Search research articles
Contact Us
Filters
Showing results (21-30 of 23) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 23 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 15, 2016
Influence of dosimetric and clinical criteria on the requirement of artificial nutrition during radiotherapy of head and neck cancer patients
Christiane Matuschek, Edwin Bölke, Caroline Geigis, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
March 2, 2011
Cystatin C - a fast and reliable biomarker for glomerular filtration rate in head and neck cancer patients
Edwin Bölke, Gisela Schieren, Stephan Gripp, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 12, 2020
Randomized phase-III-trial of concurrent chemoradiation for locally advanced head and neck cancer comparing dose reduced radiotherapy with paclitaxel/cisplatin to standard radiotherapy with fluorouracil/cisplatin: The PacCis-trial
Rainer Fietkau, Markus Hecht, Benjamin Hofner, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 23) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 23 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 15, 2016
Influence of dosimetric and clinical criteria on the requirement of artificial nutrition during radiotherapy of head and neck cancer patients
Christiane Matuschek, Edwin Bölke, Caroline Geigis, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
March 2, 2011
Cystatin C - a fast and reliable biomarker for glomerular filtration rate in head and neck cancer patients
Edwin Bölke, Gisela Schieren, Stephan Gripp, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 12, 2020
Randomized phase-III-trial of concurrent chemoradiation for locally advanced head and neck cancer comparing dose reduced radiotherapy with paclitaxel/cisplatin to standard radiotherapy with fluorouracil/cisplatin: The PacCis-trial
Rainer Fietkau, Markus Hecht, Benjamin Hofner, et al.
Page
of 3